Domestic Chinese Biopharmaceutical Companies
Chinese Pharmaceutical Market Research
Q2, 2011
Whether your organization (or department) views domestic Chinese pharmaceutical companies as a competitor, complementor, or as a catalyst, they are becoming an increasing force in the global healthcare industry. While it is not easy to get summarized company-specific information on domestic Chinese pharmaceutical companies, ISR has done the legwork for you.
In this report we profile 18 of the largest and fastest growing domestic Chinese pharmaceutical companies. We profile their corporate structure, current products, therapeutic areas of focus, R&D efforts, and financial performance. We think you'll find this report to be a superior source of information on some of China's largest and fastest growing pharmaceutical companies.
This report contains over 200 pages of information and analysis. The companies profiled in this report accounted for nearly $15 billion USD in revenue in 2010 and over $1.2 billion USD in net income.
Companies Profiled: |
||
|
|
Sample Chart:
Similar Reports:
Purchasers of this report also purchased the 2011 CRO Quality Benchmarking Report.
